Bruker Corporation
BRKR
Classificação em ações
#2373
Bruker Corporation stands as a prominent global developer, manufacturer, and... Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
Preço da ação
$54.54
Última sincronização: 2026-10-16
Valor de mercado
$8.31B
Variação (1 dia)
-3.55%
Variação (1 ano)
47.47%
País
US
Negociar Bruker Corporation (BRKR)
Categoria
Healthcare
Margem Operacional de Bruker Corporation (BRKR)
Margem Operacional em October 2026 TTM: 3.61%
De acordo com os relatórios financeiros mais recentes e o preço das ações da Bruker Corporation, a margem operacional atual (TTM) é 3.61%. No final de 2023, a margem operacional era 14.74%.
Histórico da Margem Operacional da Bruker Corporation de 2000 a 2026
Margem Operacional no final de cada ano
| Ano | Margem Operacional | Alterar |
|---|---|---|
| 2026 (TTM) | 3.61% | -51.99% |
| 2024 | 7.52% | -48.98% |
| 2023 | 14.74% | -13.80% |
| 2022 | 17.10% | 0.06% |
| 2021 | 17.09% | 36.83% |
| 2020 | 12.49% | -13.98% |
| 2019 | 14.52% | 4.91% |
| 2018 | 13.84% | 13.82% |
| 2017 | 12.16% | 10.55% |
| 2016 | 11.00% | 22.63% |
| 2015 | 8.97% | 53.86% |
| 2014 | 5.83% | -27.67% |
| 2013 | 8.06% | -7.46% |
| 2012 | 8.71% | -7.54% |
| 2011 | 9.42% | -21.04% |
| 2010 | 11.93% | -2.77% |
| 2009 | 12.27% | 25.59% |
| 2008 | 9.77% | 7.01% |
| 2007 | 9.13% | 29.69% |
| 2006 | 7.04% | 97.20% |
| 2005 | 3.57% | -1,015.38% |
| 2004 | -0.39% | -89.49% |
| 2003 | -3.71% | -175.10% |
| 2002 | 4.94% | 39.94% |
| 2001 | 3.53% | 267.71% |
| 2000 | 0.96% | 0.00% |
Margem Operacional de empresas semelhantes ou concorrentes
| Empresa | Margem Operacional | Diferença na Margem Operacional | País |
|---|---|---|---|
| 17.03% | -95.28% |
US
|
|
| 17.86% | -95.05% |
IE
|
|
| 22.03% | -93.90% |
US
|
|
| 21.46% | -94.06% |
US
|
|
| 0.00% | - |
DE
|
O que é a Margem Operacional de uma empresa?
A Margem Operacional é um indicador essencial para avaliar a rentabilidade de uma empresa. Margens operacionais mais altas geralmente são melhores, pois mostram que uma empresa consegue vender seus produtos ou serviços por muito mais do que o custo de produzi-los. É calculada dividindo os lucros da empresa pela sua receita.